UPDATE 1-U.S. FDA approves Vanda's circadian rhythm drug Hetlioz

Jan 31 (Reuters) - Vanda Pharmaceuticals Inc said on Friday that U.S. health regulators have approved its experimental drug to regulate the internal body clocks of blind patients and help normalize...

from Reuters: Hot Stocks http://ift.tt/1depSv7